-
February 26, 2019PREVIEW
Use of select sodium–glucose cotransporter-2 inhibitors (SGLT2i) resulted in significant reductions in the risk of major cardiovascular (CV) events in patients with diabetes and established CV...
-
January 22, 2019PREVIEW
Approximately 14% of patients with type 2 diabetes—or one in seven—who are not using insulin therapy routinely monitor their blood glucose despite recommendations against it, according to a...
-
January 7, 2019PREVIEW
Use of dapagliflozin (Farxiga—AstraZeneca) in patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular (CV) disease resulted in a significant reduction in the risk...
-
October 29, 2018PREVIEW
The benefits of low-dose aspirin in preventing serious vascular events in patients with diabetes and no evidence of cardiovascular (CV) disease did not outweigh the risk of major bleeding,...
-
October 1, 2018PREVIEW
Approximately one-quarter of older adults (≥75 y) with type 2 diabetes were treated with medications associated with a high risk of hypoglycemia to achieve tight glycemic control, according to an...
Pages
